Bank Of New York Mellon Corp Viatris Inc Transaction History

Bank Of New York Mellon Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$8.72 - $11.56 $110 Million - $145 Million	12,582,474 New	12,582,474 $140 Million
Q3 2022 Nov 14, 2022	SELL	$8.48 - $11.13 $16.3 Million - $21.4 Million	-1,920,633 Reduced 16.86%	9,474,316 $80.7 Million
Q2 2022 Aug 15, 2022	BUY	$9.95 - $12.27 $3.29 Million - $4.05 Million	330,193 Added 2.98%	11,394,949 $119 Million
Q1 2022 May 11, 2022	SELL	$9.81 - $15.4 $33.9 Million - $53.3 Million	-3,458,544 Reduced 23.81%	11,064,756 $120 Million
Q4 2021 Feb 11, 2022	SELL	$12.09 - $14.68 $19.9 Million - $24.2 Million	-1,649,028 Reduced 10.2%	14,523,300 $196 Million
Q3 2021 Nov 12, 2021	SELL	$13.25 - $15.13 $2.06 Million - $2.35 Million	-155,486 Reduced 0.95%	16,172,328 $219 Million
Q2 2021 Aug 11, 2021	BUY	$12.97 - $16.15 $62.2 Million - $77.5 Million	4,796,966 Added 41.6%	16,327,814 $233 Million
Q1 2021 May 13, 2021	BUY	$13.59 - $18.54 $7.2 Million - $9.83 Million	530,163 Added 4.82%	11,530,848 $161 Million
Q4 2020 Feb 09, 2021	BUY	$14.3 - $18.74 $157 Million - $206 Million	11,000,685 New	11,000,685 $206 Million

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.